The 5 key players our AI Stroke Detection report profiles, and other companies free public records show in this market.
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Viz.ai | — | 66 reports |
| 2 | RapidAI | — | 33 reports |
| 3 | Brainomix | — | 33 reports |
| 4 | Methinks AI | — | 33 reports |
| 5 | Aidoc |
aidoc.com (opens in a new tab) | 165 reports |
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
GE Healthcare |
|
| Ge Medical Systems, LLC |
|
| Methinks Software, S.L |
|
| GE Medical Systems SCS |
|
| Infervision |
|
| Ischemaview, Inc. |
|
| Aramis Global AI Consultancies, LLC |
|
| Mobia Medical, Inc. |
|
Source: FDA 510(k) and PMA databases, 510(k) clearances and PMA approvals since 2015 for devices whose name has this market's words. Retrieved 13 Nov 2026.
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.